Schrodinger Inc. (SDGR) Social Stream



Schrodinger Inc. (SDGR): $16.24

-0.24 (-1.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Featured Post From StockTwits About SDGR

$SDGR Selloff is unwarranted IMO. Good revenue growth from SW side of the business. Increased expenses are to drive further platform growth and to fund in-house clinical trials. Clinical stage biotech with upwards of 20% revenue growth w/ no approved drugs yet? Don't think you'll find that anywhere in biotech land. The deal w/ $NVDA is under appreciated as well. Very early innings of using this sort of simulation tool for chemistry/biochemistry. Quantum computing will unlock untold capability in chemical bond modeling. They are building the foundation for multi-decade growth. Many applications outside of bio that will unlock further growth for the SW business. Long, think we may see mid to low 50s but this is a buying opportunity.
WatchingClosely, published August 12, 2021

What Else are SDGR Traders Talking About?


Other tickers frequently mentioned alongside SDGR is NVDA.

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.5508 seconds.